Kala Pharmaceuticals Inc. Stock
Kala Pharmaceuticals Inc. took a tumble today and lost -€0.206 (-4.290%).
Kala Pharmaceuticals Inc. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 15 € there is potential for a 226.23% increase which would mean more than doubling the current price of 4.6 € for Kala Pharmaceuticals Inc..
So far the community has only identified positive things for Kala Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Kala Pharmaceuticals Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kala Pharmaceuticals Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Kala Pharmaceuticals Inc. | -4.290% | -10.108% | -14.694% | -48.854% | -29.479% | -96.404% | - |
Evolus Inc | 1.410% | -0.690% | 2.857% | 71.429% | 59.116% | 114.925% | - |
Ardelyx Inc. | 2.640% | 6.034% | 0.601% | 47.896% | -1.488% | 390.862% | 27.539% |
Brainstorm Cell | 2.590% | 2.830% | -22.143% | -48.341% | -3.540% | -92.431% | -93.897% |
Comments
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $21.00 to $18.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $22.00 to $21.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat